Purchases and Sales Made in Q2 2023 in Cyclacel Pharmaceuticals, Inc. (CYCC)
This table provides information about the institutional ownership of Cyclacel Pharmaceuticals, Inc. (CYCC) during Q2 2023. The information is specifically focused on institutions that hold shares of Cyclacel Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
12.3KNew |
$6.4K - $9.36K
|
12.3K
$4.06K
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
7.08K+ 157.0% |
$3.68K - $5.38K
|
11.6K
$3.82K
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
1K+ 0.59% |
$520 - $760
|
171K
$56.3K
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
BUY
|
- |
171New |
$88.9 - $130
|
171
$56.4
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 0.7% |
$2.08 - $3.04
|
579
$191
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-36- 0.99% |
$18.7 - $27.4
|
3.61K
$1.19K
|
|
Aug 04, 2023
Q2 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-919- 98.18% |
$478 - $698
|
17
$5.61
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-3.95K- 17.99% |
$2.05K - $3K
|
18K
$5.94K
|
|
Aug 07, 2023
Q2 2023
|
Mc Ilrath & Eck, LLC
|
SELL
|
- |
-16.3K- 62.04% |
$8.5K - $12.4K
|
10K
$3.3K
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-68K- 57.11% |
$35.4K - $51.7K
|
51.1K
$16.9K
|
|
Aug 14, 2023
Q2 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-71.3K- 9.68% |
$37.1K - $54.2K
|
665K
$219K
|